Timing of oral anticoagulation therapy in the treatment of angiographically proven acute pulmonary embolism
- 1 August 1987
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 147 (8) , 1469-1473
- https://doi.org/10.1001/archinte.147.8.1469
Abstract
Research from JAMA Internal Medicine — Timing of Oral Anticoagulation Therapy in the Treatment of Angiographically Proven Acute Pulmonary EmbolismThis publication has 8 references indexed in Scilit:
- SAFETY AND EFFICACY OF WARFARIN STARTED EARLY AFTER SUBMASSIVE VENOUS THROMBOSIS OR PULMONARY EMBOLISMThe Lancet, 1986
- Decrease in protein C antigen and formation of an abnormal protein soon after starting oral anticoagulant therapyBritish Journal of Haematology, 1984
- Different Intensities of Oral Anticoagulant Therapy in the Treatment of Proximal-Vein ThrombosisNew England Journal of Medicine, 1982
- The inhibition of blood coagulation by activated protein C through the selective inactivation of activated factor VBiochimica et Biophysica Acta (BBA) - Enzymology, 1979
- Heparin therapy: A randomized prospective studyAmerican Heart Journal, 1979
- HÆMORRHAGIC COMPLICATIONS OF HEPARIN THERAPYThe Lancet, 1977
- Drug Spotlight Program: Guidelines for Heparin TherapyAnnals of Internal Medicine, 1974
- STUDIES ON THE COUMARIN ANTICOAGULANT DRUGS: THE PHARMACODYNAMICS OF WARFARIN IN MAN*Journal of Clinical Investigation, 1963